NextCell publishes its Interim Report 2 2022/2023 news.cision.com/nextcell-pha…
NextCell Pharma offentliggör Delårsrapport 2 för 2022/2023 news.cision.com/se/nextcell-…
Banbrytande multiplicering av blodstamceller news.cision.com/se/nextcell-…
Breakthrough multiplication of blood stem cells news.cision.com/nextcell-pha…
NextCell invited speaker at European Wound Management Association Meeting in Milan news.cision.com/nextcell-pha…
NextCell inbjuden talare vid European Wound Management Association i Milano news.cision.com/se/nextcell-…
NextCells seminarium fas I/II klinisk studie i typ I-diabetes accepteras för publicering news.cision.com/se/nextcell-…
NextCell´s publication of the phase I/II clinical trial in type I diabetes accepted news.cision.com/nextcell-pha…
NextCells forskningschef vald till ISCT:s europeiska regionala sekreterare news.cision.com/se/nextcell-…
NextCell’s CSO elected to ISCT European Regional Secretary news.cision.com/nextcell-pha…
NextCell Pharma offentliggör Delårsrapport 1 för 2022/2023 news.cision.com/se/nextcell-…
NextCell publishes its Interim Report 1 2022/2023 news.cision.com/nextcell-pha…
ProTrans-studie i COVID-19 utökas till att även omfatta behandling av allvarlig lunginflammation orsakad av influensa, RS och HMP-virus news.cision.com/se/nextcell-…
ProTrans study in COVID-19 expanded to include treatment of severe pneumonia induced by influenza A, RSV and HMP virus news.cision.com/se/nextcell-…
Fantastiskt vinterprat av Olof Wretling om typ-1 diabetes. #nextcellpharma
#stamceller
#tad1
#barndiabetesfonden
#beatdiabetes
#cellaviva instagram.com/p/Cm_XEeUy1Co/…
Cellterapi testas på barn och unga med diabetes typ 1 forskning.se/2022/11/11/cell… #nextcellpharma #cellaviva #protrans
